Ming Kuang

Changchun University of Chinese Medicine — China

Medicine · Health Sciences

51h-index7.9kcitations625works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(142), Hepatocellular Carcinoma Treatment and Prognosis(138), Cholangiocarcinoma and Gallbladder Cancer Studies(74), RNA modifications and cancer(61), Cancer Mechanisms and Therapy(60)

Publications624 total

Investigating the Protective Mechanisms of Ginseng-Natto Composite Fermentation Products in Alzheimer’s Disease: A Gut Microbiota and Metabolomic Approach
Pharmaceuticals·2026Open Access
Retraction Note: Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy
Nature Communications·2025Open Access
Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma
Nature Communications·2025· 1 citedOpen Access
Figure S5 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
2025Open Access
Table S6 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
2025Open Access
Figure S2 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
2025Open Access
Supplementary Table S2 from METTL1-Mediated m<sup>7</sup>G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2025Open Access
Table S4 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
2025Open Access
Table S1 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
2025Open Access
Table S9 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
2025Open Access
Supplementary Figures from METTL1-Mediated m<sup>7</sup>G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2025Open Access
Table S8 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
2025Open Access
Figure S7 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
2025Open Access
Figure S3 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
2025Open Access
Table S2 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
2025Open Access
Table S7 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
2025Open Access
Figure S11 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
2025Open Access
Supplementary Table S1 from METTL1-Mediated m<sup>7</sup>G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2025Open Access
Figure S6 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
2025Open Access
Figure S4 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
2025Open Access
page 1 of 32Next →

Frequent Co-authors

Sui Peng(17), Shuling Chen(12), Wei Wang(11), Xiaoyan Xie(9), Ming‐De Lu(8), Xin Li(7), Zhenwei Peng(7), Shunli Shen(7), Jun Yu(7), Lixia Xu(7), Baogang Peng(6), Zihao Dai(5), Shaoqiang Li(5), Shunro Matsumoto(5), Shi‐Ting Feng(5), Qian Zhou(5), Han Xiao(4), Shuibin Lin(4), Bin Li(4), Manxia Lin(4)